COVID-19 vaccine safety, dueling efficacy standards, and representation of groups from racial and ethnic minorities to children drew focus Thursday at arguably the most watched FDA advisory committee meeting ever.

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) featured a brief appearance by Peter Marks, MD, PhD, director of the agency's Center for Biologics Evaluation and Research, who called this, "an exceptionally well-attended advisory committee meeting." In addition to the FDA's website, the meeting was broadcast on YouTube, with over 15,000 views when it concluded in the early evening.

Read more